Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500107062Phase 4Not yet recruiting
Phase 4, randomised trial of fospropofol disodium in intracerebral hemorrhage (ICH) (3 arms), sponsored by Hainan People's Hospital. Primary endpoint: Incidence of post-induction hypotension. Planned start Aug 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500107062.